Outpost Medicine

Clinical-stage biopharmaceutical company addressing unmet needs in urologic and gastrointestinal disorders

Outpost Medicine is a Frazier-founded company focused on developing novel therapeutics for the treatment of urologic and gastrointestinal disorders. The company’s lead product (OP-352), which was licensed from Arena Pharmaceuticals, is in development for the treatment of stress urinary incontinence (SUI) and fecal incontinence.

Year of Investment
Life Sciences
Boston, Massachusetts